SCM
ADMS

Sio Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Sio Capital Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-35,000
Closed -$1.19M – 57
2017
Q4 		$1.19M Buy
+35,000
New +$977K 0.67% 36
2017
Q1 		– Sell
-69,215
Closed -$1.17M – 68
2016
Q4 		$1.17M Buy
69,215
+3,105
+5% +$48K 0.68% 37
2016
Q3 		$1.08M Buy
66,110
+9,610
+17% +$146K 0.75% 29
2016
Q2 		$855K Buy
56,500
+36,500
+183% +$602K 0.44% 35
2016
Q1 		$289K Sell
20,000
-97,257
-83% -$1.64M 0.11% 39
2015
Q4 		$3.32M Buy
117,257
+15,491
+15% +$261K 1.47% 23
2015
Q3 		$1.7M Buy
+101,766
New +$2.32M 1.17% 25

Other funds holding ADMS

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sio Capital Management's ADMS Position: Q1 2018 in Review

Sio Capital Management sold out of Adamas Pharmaceuticals (ADMS) in Q1 2018, closing a stake of 35,000 shares — an estimated $1.19M sold.

Sio Capital Management first reported a position in ADMS in Q3 2015 and held it in 7 quarters. The position peaked at $3.32M in Q4 2015. 118 funds tracked by Wall St. Rank hold ADMS as of Q1 2018.

  • Sio Capital Management reported no remaining Adamas Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Sio Capital Management sold 35,000 Adamas Pharmaceuticals shares in Q1 2018, an estimated $1.19M.
  • Sio Capital Management first reported a position in Adamas Pharmaceuticals in Q3 2015 and held it in 7 quarters.
  • Sio Capital Management's Adamas Pharmaceuticals position peaked at $3.32M in Q4 2015.
  • 118 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2018.

Based on Sio Capital Management's 13F filing for Q1 2018, filed 15 May 2018.